Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Stocchi

Showing results (71-80 of 253) with videos related to

Pageof 26
Sort By:
Clinical Neuropharmacology|November 26, 2009
Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational studyRoberta Zangaglia, Fabrizio Stocchi, Massimo Sciarretta, et al.
Clinical Neuropharmacology|February 3, 2007
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson diseaseFabrizio Stocchi, Laura Fabbri, Laszlo Vecsei, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorderFabrizio Stocchi, Giampetro Nordera, Riitta H Jokinen, et al.
Journal of Neurology|January 16, 2007
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's diseaseAstrid Thomas, Laura Bonanni, Angelo Di Iorio, et al.
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2023
Exploring depression in Alzheimer's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and managementAlessandro Padovani, Angelo Antonini, Paolo Barone, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 30, 2025
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's diseaseManon Auffret, Fran Borovecki, Beatrice Heim, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 26, 2023
Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and managementFabrizio Stocchi, Angelo Antonini, Paolo Barone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2016
Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studiesClaudia Trenkwalder, Fabrizio Stocchi, Werner Poewe, et al.
Clinical Neuropharmacology|June 11, 2004
Variation in the dopaminergic response during the day in Parkinson diseaseAlessandra Monge, Fabio Viselli, Fabrizio Stocchi, et al.
Pageof 26

Showing results (71-80 of 253) with videos related to

Sort By:
Pageof 26
Clinical Neuropharmacology|November 26, 2009
Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational studyRoberta Zangaglia, Fabrizio Stocchi, Massimo Sciarretta, et al.
Clinical Neuropharmacology|February 3, 2007
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson diseaseFabrizio Stocchi, Laura Fabbri, Laszlo Vecsei, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorderFabrizio Stocchi, Giampetro Nordera, Riitta H Jokinen, et al.
Journal of Neurology|January 16, 2007
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's diseaseAstrid Thomas, Laura Bonanni, Angelo Di Iorio, et al.
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2023
Exploring depression in Alzheimer's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and managementAlessandro Padovani, Angelo Antonini, Paolo Barone, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 30, 2025
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's diseaseManon Auffret, Fran Borovecki, Beatrice Heim, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 26, 2023
Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and managementFabrizio Stocchi, Angelo Antonini, Paolo Barone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2016
Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studiesClaudia Trenkwalder, Fabrizio Stocchi, Werner Poewe, et al.
Clinical Neuropharmacology|June 11, 2004
Variation in the dopaminergic response during the day in Parkinson diseaseAlessandra Monge, Fabio Viselli, Fabrizio Stocchi, et al.
Pageof 26